198 related articles for article (PubMed ID: 23480852)
1. BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.
Beverly LJ; Howell LA; Hernandez-Corbacho M; Casson L; Chipuk JE; Siskind LJ
Biochem J; 2013 May; 452(1):111-9. PubMed ID: 23480852
[TBL] [Abstract][Full Text] [Related]
2. The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis.
Siskind LJ; Mullen TD; Romero Rosales K; Clarke CJ; Hernandez-Corbacho MJ; Edinger AL; Obeid LM
J Biol Chem; 2010 Apr; 285(16):11818-26. PubMed ID: 20172858
[TBL] [Abstract][Full Text] [Related]
3. Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.
Wang C; Youle RJ
Oncogene; 2012 Jun; 31(26):3177-89. PubMed ID: 22056880
[TBL] [Abstract][Full Text] [Related]
4. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Chen S; Dai Y; Harada H; Dent P; Grant S
Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins.
Casson L; Howell L; Mathews LA; Ferrer M; Southall N; Guha R; Keller JM; Thomas C; Siskind LJ; Beverly LJ
PLoS One; 2013; 8(1):e54525. PubMed ID: 23342165
[TBL] [Abstract][Full Text] [Related]
6. Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events.
Mullen TD; Jenkins RW; Clarke CJ; Bielawski J; Hannun YA; Obeid LM
J Biol Chem; 2011 May; 286(18):15929-42. PubMed ID: 21388949
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mitochondrial ceramide distribution by members of the BCL-2 family.
Zhang T; Barclay L; Walensky LD; Saghatelian A
J Lipid Res; 2015 Aug; 56(8):1501-10. PubMed ID: 26059977
[TBL] [Abstract][Full Text] [Related]
8. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
11. Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis.
Gomez-Bougie P; Halliez M; Moreau P; Pellat-Deceunynck C; Amiot M
Cancer Lett; 2016 Dec; 383(2):204-211. PubMed ID: 27697610
[TBL] [Abstract][Full Text] [Related]
12. Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction.
Vartak SV; Iyer D; Santhoshkumar TR; Sharma S; Mishra A; Goldsmith G; Srivastava M; Srivastava S; Karki SS; Surolia A; Choudhary B; Raghavan SC
Biochem Pharmacol; 2017 May; 131():16-28. PubMed ID: 28223017
[TBL] [Abstract][Full Text] [Related]
13. Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells.
Dai H; Ding H; Meng XW; Peterson KL; Schneider PA; Karp JE; Kaufmann SH
Genes Dev; 2015 Oct; 29(20):2140-52. PubMed ID: 26494789
[TBL] [Abstract][Full Text] [Related]
14. Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.
Chen S; Dai Y; Pei XY; Grant S
Mol Cell Biol; 2009 Dec; 29(23):6149-69. PubMed ID: 19805519
[TBL] [Abstract][Full Text] [Related]
15. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination.
Gómez-Benito M; Marzo I; Anel A; Naval J
Mol Pharmacol; 2005 Jun; 67(6):1991-8. PubMed ID: 15738311
[TBL] [Abstract][Full Text] [Related]
17. Different forms of cell death induced by putative BCL2 inhibitors.
Vogler M; Weber K; Dinsdale D; Schmitz I; Schulze-Osthoff K; Dyer MJ; Cohen GM
Cell Death Differ; 2009 Jul; 16(7):1030-9. PubMed ID: 19390557
[TBL] [Abstract][Full Text] [Related]
18. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
[TBL] [Abstract][Full Text] [Related]
19. MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.
Konopleva M; Milella M; Ruvolo P; Watts JC; Ricciardi MR; Korchin B; McQueen T; Bornmann W; Tsao T; Bergamo P; Mak DH; Chen W; McCubrey J; Tafuri A; Andreeff M
Leukemia; 2012 Apr; 26(4):778-87. PubMed ID: 22064351
[TBL] [Abstract][Full Text] [Related]
20. Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression.
Olberding KE; Wang X; Zhu Y; Pan J; Rai SN; Li C
Cancer Biol Ther; 2010 Nov; 10(9):918-29. PubMed ID: 20818182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
